Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC3 | O15379 | 2/20 | 0.63 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.63 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.63 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.63 |
| ▸ | MMP8 | P22894 | 7/20 | 0.60 |
| ▸ | MMP2 | P08253 | 5/20 | 0.60 |
| ▸ | MMP9 | P14780 | 5/20 | 0.60 |
| ▸ | MMP1 | P03956 | 6/20 | 0.57 |
| ▸ | MMP3 | P08254 | 6/20 | 0.57 |
| ▸ | MMP7 | P09237 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.51 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.51 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13103460 | 0.86 | HDAC8 (0.61) | HDAC3HDAC1HDAC8HDAC6MMP8 | |
| SCHEMBL3437053 | 0.86 | HDAC8 (0.61) | HDAC3HDAC1HDAC8HDAC6MMP8 | |
| SCHEMBL13103439 | 0.84 | CYP1A2 (0.63) | HDAC3HDAC1HDAC8HDAC6MMP8 | |
| SCHEMBL10521966 | 0.83 | FOLH1 (0.72) | FOLH1GRIK1 | |
| SCHEMBL10769990 | 0.83 | FOLH1 (0.72) | FOLH1GRIK1 | |
| SCHEMBL13103429 | 0.82 | HDAC3 (0.57) | HDAC3HDAC1HDAC8HDAC6MMP8 | |
| SCHEMBL7418989 | 0.81 | MMP3 (0.61) | HDAC3HDAC1HDAC8HDAC6MMP8 | |
| SCHEMBL9206899 | 0.79 | MMP1 (0.50) | HDAC3HDAC1HDAC8HDAC6MMP8 | |
| SCHEMBL5966641 | 0.78 | FOLH1 (0.70) | FOLH1GRIK1 | |
| SCHEMBL27423810 | 0.78 | FOLH1 (0.70) | FOLH1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1812010-A2 | USE OF NA+/ K+-ATPASE INHIBITORS AND ANTAGONISTS THEREOF | BTG International Limited (GB) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006044916-A2 | USE OF NA+/ K+-ATPASE INHIBITORS AND ANTAGONISTS THEREOF | BIONAUT PHARMACEUTICALS, INC. (US) | 2006-04-27 | — | — | WO | disclosed |